ontology files generated from the newly created flora editing environment and renamed for 1.5. Also, commenting out the knowledgebaseupdate in startup_listeners.txt

productMods/WEB-INF/filegraph/tbox/scires-1.5.owl

@@ -1,16 +1,25 @@
 <rdf:RDF
+    xmlns:vitro-public="http://vitro.mannlib.cornell.edu/ns/vitro/public#"
     xmlns:geo="http://aims.fao.org/aos/geopolitical.owl#"
+    xmlns:skos="http://www.w3.org/2004/02/skos/core#"
+    xmlns:ero="http://purl.obolibrary.org/obo/"
+    xmlns:event="http://purl.org/NET/c4dm/event.owl#"
+    xmlns:pvs="http://vivoweb.org/ontology/provenance-support#"
     xmlns:dcelem="http://purl.org/dc/elements/1.1/"
     xmlns:j.0="http://www.w3.org/2006/12/owl2-xml#"
     xmlns:scirr="http://vivoweb.org/ontology/scientific-research-resource#"
+    xmlns:vivo="http://vivoweb.org/ontology/core#"
     xmlns:j.1="http://purl.org/vocab/vann/"
     xmlns:vitro="http://vitro.mannlib.cornell.edu/ns/vitro/0.7#"
     xmlns:j.2="http://www.w3.org/2008/05/skos#"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:afn="http://jena.hpl.hp.com/ARQ/function#"
+    xmlns:bibo="http://purl.org/ontology/bibo/"
+    xmlns:foaf="http://xmlns.com/foaf/0.1/"
     xmlns:j.3="http://www.w3.org/2003/06/sw-vocab-status/ns#"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:dcterms="http://purl.org/dc/terms/"
+    xmlns:scires="http://vivoweb.org/ontology/scientific-research#"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" > 
   <rdf:Description rdf:about="http://purl.obolibrary.org/obo/">
@@ -27,11 +36,6 @@
     <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#DatatypeProperty"/>
     <vitro:descriptionAnnot rdf:datatype="http://www.w3.org/2001/XMLSchema#string">number of human participants in the study (trial).</vitro:descriptionAnnot>
   </rdf:Description>
-  <rdf:Description rdf:nodeID="A0">
-    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Restriction"/>
-    <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/ERO_0000460"/>
-    <owl:allValuesFrom rdf:resource="http://purl.org/ontology/bibo/Document"/>
-  </rdf:Description>
   <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000272">
     <rdfs:subClassOf rdf:resource="http://purl.org/ontology/bibo/Document"/>
     <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Class"/>
@@ -43,6 +47,11 @@
     <rdfs:domain rdf:resource="http://purl.org/ontology/bibo/Document"/>
     <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#ObjectProperty"/>
   </rdf:Description>
+  <rdf:Description rdf:nodeID="A0">
+    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Restriction"/>
+    <owl:onProperty rdf:resource="http://purl.obolibrary.org/obo/ERO_0000460"/>
+    <owl:allValuesFrom rdf:resource="http://purl.org/ontology/bibo/Document"/>
+  </rdf:Description>
   <rdf:Description rdf:about="http://vivoweb.org/ontology/scientific-research#Phase4ClinicalTrial">
     <vitro:shortDef rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 4 Clinical Trial</vitro:shortDef>
     <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Class"/>
@@ -130,14 +139,14 @@ NOTE that we are not addressing for now the issue of whether a foaf:Person is a
   </rdf:Description>
   <rdf:Description rdf:about="http://vivoweb.org/ontology/scientific-research#Phase3ClinicalTrial">
     <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/ERO_0000016"/>
+    <vitro:descriptionAnnot rdf:datatype="http://www.w3.org/2001/XMLSchema#string">In Phase 3 trials, an experimental study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the experimental drug or treatment to be used safely.
+</vitro:descriptionAnnot>
     <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Class"/>
     <vitro:shortDef rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 3 Clinical Trial</vitro:shortDef>
-    <vitro:descriptionAnnot rdf:datatype="http://www.w3.org/2001/XMLSchema#string">In Phase 3 trials, an experimental study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the experimental drug or treatment to be used safely.
-</vitro:descriptionAnnot>
   </rdf:Description>
   <rdf:Description rdf:about="http://purl.obolibrary.org/obo/ERO_0000004">
-    <rdfs:subClassOf rdf:nodeID="A0"/>
     <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Class"/>
+    <rdfs:subClassOf rdf:nodeID="A0"/>
     <vitro:descriptionAnnot rdf:datatype="http://www.w3.org/2001/XMLSchema#string">An implement used to facilitate work, especially precision work.</vitro:descriptionAnnot>
     <vitro:shortDef rdf:datatype="http://www.w3.org/2001/XMLSchema#string">An implement used to facilitate work, especially precision work.</vitro:shortDef>
     <rdfs:subClassOf rdf:resource="http://vivoweb.org/ontology/core#Equipment"/>